Swiss National Bank Seagen Inc. Transaction History

Swiss National Bank

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 08, 2023	SELL	$191.51 - $216.16 $10.4 Million - $11.8 Million	-54,500 Reduced 10.75%	452,300 $96 Million
Q2 2023 Aug 09, 2023	SELL	$187.64 - $206.25 $8.61 Million - $9.47 Million	-45,900 Reduced 8.3%	506,800 $97.5 Million
Q1 2023 May 10, 2023	SELL	$127.59 - $203.08 $1.21 Million - $1.93 Million	-9,500 Reduced 1.69%	552,700 $112 Million
Q4 2022 Feb 08, 2023	SELL	$117.37 - $139.17 $4.24 Million - $5.02 Million	-36,092 Reduced 6.03%	562,200 $72.2 Million
Q3 2022 Nov 09, 2022	BUY	$135.27 - $180.11 $121,743 - $162,099	900 Added 0.15%	598,292 $81.9 Million

Q2 2022 Aug 09, 2022	BUY	$108.81 - $179.33 $369,954 - $609,722	3,400 Added 0.57%	597,392 $106 Million
Q1 2022 May 09, 2022	BUY	$119.61 - $157.85 $9.01 Million - $11.9 Million	75,300 Added 14.52%	593,992 $85.6 Million
Q4 2021 Feb 08, 2022	SELL	$142.57 - $190.86 $2.89 Million - $3.87 Million	-20,300 Reduced 3.77%	518,692 $80.2 Million
Q3 2021 Nov 08, 2021	SELL	$142.45 - $169.82 $2.14 Million - $2.55 Million	-15,000 Reduced 2.71%	538,992 $91.5 Million
Q2 2021 Aug 06, 2021	BUY	$135.08 - $161.1 $4.47 Million - $5.33 Million	33,100 Added 6.35%	553,992 $87.5 Million
Q1 2021 May 07, 2021	BUY	$137.51 - $190.8 $3.59 Million - $4.98 Million	26,100 Added 5.27%	520,892 $72.3 Million
Q4 2020 Feb 05, 2021	BUY	$164.63 - $211.93 $81.5 Million - $105 Million	494,792 New	494,792 $86.7 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

Stay updated on Swiss National Bank with notifications on news.